Harnessing benefits of helping others: A randomized controlled trial testing expressive helping to address survivorship problems after hematopoietic stem cell transplant.
Christine Rini(Hackensack University Medical Center), William H. Redd(Icahn School of Medicine at Mount Sinai), Luis Isola(Mount Sinai Medical Center), Annette L. Stanton(University of California, Los Angeles), Scott D. Rowley(Johns Hopkins Hospital), Heiðdís Valdimarsdóttir(Reykjavík University), Lisa M. Wu(Northwestern University), Gary Winkel(The Graduate Center, CUNY), Jane E. Austin(William Paterson University)
Cited by 57
Related Papers
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide
|New England Journal of Medicine|1986|441